Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday
12 Health Care Stocks Moving In Thursday's After-Market Session
Sangamo Therapeutics Stock Surges After The Bell: What's Going On?
CRISPR Therapeutics Set to Snap Six Straight Sessions of Losses
Scotiabank Maintains Sector Perform on Apellis Pharmaceuticals, Raises Price Target to $31
70107480 OP : I think its best to hold on to our cash, it may go Green from time to time, but there will be more Red in the days and months to come, i think.